Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase: A putative mechanism of degeneration

Brain Research Reviews

Volumn 29, Issue 1, 1999, Pages 121-135

  Morrison, Brett M ^a   Morrison, John H ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Neurobiology of Aging Laboratories   (United States)

Author keywords

Excitotoxicity; Neurofilament; Transgenic

Indexed keywords

ALPHA TOCOPHEROL; AMPA RECEPTOR; CALCIUM; CALCIUM CHANNEL; CALPAIN; GLUTAMATE RECEPTOR; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PEROXYNITRITE; PROTEINASE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CALCIUM CELL LEVEL; CHANNEL GATING; DISEASE COURSE; GENE MUTATION; GENETIC LINKAGE; MITOCHONDRION; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE FUNCTION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYMPTOMATOLOGY; TRANSGENIC MOUSE;

EID: 0032908774     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(98)00049-6     Document Type: Article

References (140)

1. K. Abe, L.-H. Pan, M. Watanabe, T. Kato, Y. Itoyama, Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis, Neurosci. Lett. 199 (1995) 152-154.
2. 2+ binding by Myxicola neurofilament proteins, Cell Calcium 11 (1990) 361-370.
3. R.D. Adams, M. Victor, A.H. Ropper, Principles of Neurology, 6th edn., McGraw-Hill, New York, 1997.
4. M.E. Alexianu, B.-K. Ho, A.H. Mohamed, V. La Bella, R.G. Smith, S.H. Appel, The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis, Ann. Neurol. 36 (1994) 846-858.
5. C. Andressen, I. Blümcke, M.R. Celio, Calcium-binding proteins: selective markers of nerve cells, Cell Tissue Res. 271 (1993) 181-208.
6. M. Antal, T.F. Freund, E. Polgar, Calcium-binding proteins, parvalbumin- and calbindin-D28k-immunoreactive neurons in the rat spinal cord and dorsal root ganglia: a light and electron microscopic study, J. Comp. Neurol. 295 (1990) 467-484.
7. D.M. Armstrong, M.D. Ikonomovic, AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal dentate gyrus of patients with Alzheimer's disease - evidence for hippocampal plasticity, Mol. Chem. Neuropathol. 28 (1996) 59-64.
8. D.M. Armstrong, M.D. Ikonomovic, R. Sheffield, R.J. Wenthold, AMPA-selective glutamate receptor subtype immunoreactivity in the entorhinal cortex of non-demented elderly and patients with Alzheimer's disease, Brain Res. 639 (1994) 207-216.
9. M.F. Beal, R.J. Ferrante, S.E. Browne, R.T. Matthews, N.W. Kowall, R.H. Brown Jr., Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis, Ann. Neurol. 42 (1997) 646-654.
10. J.S. Beckman, H. Ischiropoulos, L. Zhu, M. van der Woerd, C. Smith, J. Chen, J. Harrison, J.C. Martin, M. Tsai, Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite, Arch. Biochem. Biophys. 298 (1992) 438-445.
11. G. Bensimon, L. Lacomblez, V. Meininger, A.R.S. Group, A controlled trial of riluzole in amyotrophic lateral sclerosis, N. Engl. J. Med. 330 (1994) 585-591.
12. D.R. Borchelt, M.K. Lee, H.S. Slunt, M. Guarnieri, Z.-S. Xu, P.C. Wong, R.H. Brown Jr., D.L. Price, S.S. Sisodia, D.W. Cleveland, Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity, Proc. Natl. Acad. Sci. USA 91 (1994) 8292-8296.
13. J. Boulter, M. Hollmann, A. O'Shea-Greenfield, M. Hartley, E. Deneris, C. Maron, S. Heinemann, Molecular cloning and functional expression of glutamate receptor subunit genes, Science 249 (1990) 1033-1037.
14. L.A. Bristol, J.D. Rothstein, Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex, Ann. Neurol. 39 (1996) 676-679.
15. N. Brose, G.W. Huntley, Y. Stern-Bach, G. Sharma, J.H. Morrison, S.F. Heinemann, Differential assembly of coexpressed glutamate receptor subunits in neurons of rat cerebral cortex, J. Biol. Chem. 269 (1994) 16780-16784.
16. L.I. Bruijn, M.F. Beal, M.W. Becher, J.B. Schulz, P.C. Wong, D.L. Price, D.W. Cleveland, Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant, Proc. Natl. Acad. Sci. USA 94 (1997) 7606-7611.
17. L.I. Bruijn, M.W. Becher, M.K. Lee, K.L. Anderson, N.A. Jenkins, N.G. Copeland, S.S. Sisodia, J.D. Rothstein, D.R. Borchelt, D.L. Price, D.W. Cleveland, ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions, Neuron 18 (1997) 327-338.
18. G.R. Buettner, The pecking order of free radicals and antioxidants: lipid peroxidation, a-tocopherol, and ascorbate, Arch. Biochem. Biophys. 300 (1993) 535-543.
19. M.L. Bush, J.S. Miyashiro, V.M. Ingram, Activation of a neurofilament kinase, a tau kinase, and a tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC-12 cells, Proc. Natl. Acad. Sci. USA 92 (1995) 1861-1865.
20. E. Carafoli, Intracellular calcium homeostasis, Annu. Rev. Biochem. 56 (1987) 395-433.
21. 2+ concentration in transfected neuroblastoma SH-SY5Y cells, FEBS Lett. 414 (1997) 365-368.
22. S.G. Carriedo, H.Z. Yin, J.H. Weiss, Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro, J. Neurosci. 16 (1996) 4069-4079.
23. M.R. Celio, Calbindin D-28k and parvalbumin in the rat nervous system, Neuroscience 35 (1990) 375-475.
24. P.S. Chard, D. Bleakman, S. Christakos, C.S. Fullmer, R.J. Miller, Calcium buffering properties of calbindin D-28k and parvalbumin in rat sensory neurones, J. Physiol. 472 (1993) 341-357.
25. A. Cheramy, L. Barbeito, G. Godeheu, J. Glowinski, Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo, Neurosci. Lett. 147 (1992) 209-212.
26. A.Y. Chiu, P. Zhai, M.C. Dal Canto, T.M. Peters, Y.W. Kwon, S.M. Prattis, M.E. Gurney, Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis, Mol. Cell. Neurosci. 6 (1995) 349-362.
27. D.W. Choi, Ionic dependence of glutamate neurotoxicity, J. Neurosci. 7 (1987) 369-379.
28. D.W. Choi, J. Koh, S. Peters, Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists, J. Neurosci. 8 (1988) 185-196.
29. J.-F. Collard, F. Cote, J.-P. Julien, Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis, Nature 375 (1995) 61-64.
30. F. Côté, J.-F. Collard, J.-P. Julien, Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis, Cell 73 (1993) 35-46.
31. J.P. Crow, J.B. Sampson, Y. Zhuang, J.A. Thompson, J.S. Beckman, Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite, J. Neurochem. 69 (1997) 1936-1944.
32. M.C. Dal Canto, M.E. Gurney, Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis, Am. J. Pathol. 145 (1994) 1271-1279.
33. M.C. Dal Canto, M.E. Gurney, Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS), Brain Res. 676 (1995) 25-40.
34. M.C. Dal Canto, M.E. Gurney, A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis, Acta Neuropathol. 93 (1997) 537-550.
35. H.-X. Deng, A. Hentati, J.A. Tainer, Z. Iqbal, A. Cayabyab, W.-Y. Hung, E.D. Getzoff, P. Hu, B. Herzfeldt, R.P. Roos, C. Warner, G. Deng, E. Soriano, C. Smyth, H.E. Parge, A. Ahmed, A.D. Roses, R.A. Hallewell, M.A. Pericak-Vance, T. Siddique, Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase, Science 261 (1993) 1047-1051.
36. M. Deshmukh, E.M. Johnson Jr., Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons, Mol. Pharmacol. 51 (1997) 897-906.
37. A. Doble, The pharmacology and mechanism of action of riluzole, Neurology 47 (1996) S233-S241, (Suppl.).
38. L.L. Dugan, D.M. Turetsky, C. Du, D. Lobner, M. Wheeler, C.R. Almli, C.K.-F. Shen, T.-Y. Luh, D.W. Choi, T.-S. Lin, Carboxyfullerenes as neuroprotective agents, Proc. Natl. Acad. Sci. USA 94 (1997) 9434-9439.
39. H.D. Durham, J. Roy, L. Dong, D.A. Figlewicz, Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS, J. Neuropathol. Exp. Neurol. 56 (1997) 523-530.
40. M.D. Ehlers, E.T. Fung, R.J. O'Brien, R.L. Huganir, Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments, J. Neurosci. 18 (1998) 720-730.
41. R.J. Ferrante, L.A. Shinobu, J.B. Schulz, R.T. Matthews, C.E. Thomas, N.W. Kowall, M.E. Gurney, M.F. Beal, Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation, Ann. Neurol. 42 (1997) 326-334.
42. W. Freist, D.H. Gauss, Lysyl-tRNA synthetase, Biol. Chem. Hoppe-Seyler 376 (1995) 451-472.
43. I. Fridovich, Superoxide dismutases, Adv. Enzymol. Relat. Areas Mol. Biol. 41 (1974) 35-97.
44. R.M. Friedlander, R.H. Brown, V. Gagliardini, J. Wang, J. Yuan, Inhibition of ICE slows ALS in mice, Nature 388 (1997) 31.
45. J. Fujii, T. Myint, H.G. Seo, Y. Kayanoki, Y. Ikeda, N. Taniguchi, Characterization of wild-type and amyotrophic lateral sclerosis-related mutant Cu,Zn-superoxide dismutases overproduced in baculovirus-infected insect cells, J. Neurochem. 64 (1995) 1456-1461.
46. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS, Neuron 15 (1995) 193-204.
47. J.D. Glass, B.L. Schryer, J.W. Griffen, Calcium-mediated degeneration of the axonal cytoskeleton in the Ola mouse, J. Neurochem. 62 (1994) 2472-2475.
48. 2+ influx in hippocampal CA1 neurons of gerbil, J. Neurosci. 17 (1997) 6179-6188.
49. M.E. Gurney, F.B. Cuttings, P. Zhai, A. Doble, C.P. Taylor, P.K. Andrus, E.D. Hall, Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis, Ann. Neurol. 39 (1996) 147-157.
50. M.E. Gurney, H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, D.D. Alexander, J. Caliendo, A. Hentati, Y.W. Kwon, H.-X. Deng, W. Chen, P. Zhai, R.L. Sufit, T. Siddique, Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation, Science 264 (1994) 1772-1775.
51. A.J. Hale, C.A. Smith, L.C. Sutherland, V.E.A. Stoneman, V.L. Longthorne, A.C. Culhane, G.T. Williams, Apoptosis: molecular regulation of cell death, Eur. J. Biochem. 236 (1996) 1-26.
52. B. Halliwell, J.M.C. Gutteridge, C.E. Cross, Free radicals, antioxidants, and human disease: where are we now?, J. Lab. Clin. Med. 119 (1992) 598-620.
53. E. Hartmann, D. Gorlich, S. Kostka, A. Otto, R. Kraft, S. Knespel, E. Burger, T.A. Rapoport, S. Prehn, A tetrameric complex of membrane proteins in the endoplasmic reticulum, Eur. J. Biochem. 214 (1993) 375-381.
54. S.H. Hendry, E.G. Jones, P.C. Emson, D.E. Lawson, C.W. Heizmann, P. Streit, Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities, Exp. Brain Res. 76 (1989) 467-472.
55. J.L. Herrmann, E. Bruckheimer, T.J. McDonnell, Cell death signal transduction and Bcl-2 function, Biochem. Soc. Trans. 24 (1996) 1059-1065.
56. A. Hirano, Cytopathology of amyotrophic lateral sclerosis, in: L.P. Rowland (Ed.), Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases, Vol. 56, Raven Press, New York, 1991, pp. 91-101.
57. A. Hirano, L.T. Kurland, G.P. Sayre, Familial amyotrophic lateral sclerosis, Arch. Neurol. 16 (1967) 232-243.
58. N. Hirokawa, M.A. Glicksman, M.B. Willard, Organization of mammalian neurofilament polypeptides within the neuronal cytoskeleton, J. Cell Biol. 98 (1984) 1523-1536.
59. B.-K. Ho, M.E. Alexianu, L.V. Colom, A.H. Mohamed, F. Serrano, S.H. Appel, Expression of calbindin-D28k in motoneuron hybrid cells after retroviral infection with calbindin-D28k cDNA prevents amyotrophic lateral sclerosis IgG-mediated toxicity, Proc. Natl. Acad. Sci. USA 93 (1996) 6796-6801.
60. P.R. Hof, E.A. Nimchinsky, M.R. Celio, C. Bouras, J.H. Morrison, Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease, Neurosci. Lett. 152 (1993) 145-149.
61. 2+ channel diversity, Annu. Rev. Neurosci. 17 (1994) 399-418.
62. M. Hollmann, S.F. Heinemann, Cloned glutamate receptors, Annu. Rev. Neurosci. 17 (1994) 31-108.
63. M. Hollmann, A. O'Shea-Greenfield, S.W. Rogers, S. Heinemann, Cloning by functional expression of a member of the glutamate receptor family, Nature 342 (1989) 643-648.
64. A.F. Hottinger, E.G. Fine, M.E. Gurney, A.D. Zurn, P. Acbischer, The copper chelator D-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis, Eur. J. Neurosci. 9 (1997) 1548-1551.
65. J. Hugon, J.M. Vallat, Abnormal distribution of phosphorylated neurofilaments in neuronal degeneration induced by kainic acid, Neurosci. Lett. 119 (1990) 45-48.
66. C. Ikonomidou, Y. Qin Qin, J. Labruyere, J.W. Olney, Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis, J. Neuropath. Exp. Neurol. 55 (1996) 211-224.
67. H. Ischiropoulos, L. Zhu, J. Chen, M. Tsai, J.C. Martin, C.D. Smith, J.S. Beckman, Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase, Arch. Biochem. Biophys. 298 (1992) 431-437.
68. A. Kamal-Eldin, L.-A. Appelqvist, The chemistry and antioxidant properties of tocopherols and tocotrienols, Lipids 31 (1996) 671-701.
69. K. Keinanen, W. Wisden, B. Sommer, P. Werner, A. Herb, T.A. Verdoorn, B. Sakmann, P.H. Seeburg, A family of AMPA-selective glutamate receptors, Science 249 (1990) 556-560.
70. J. Kong, Z. Xu, Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD-1, J. Neurosci. 18 (1998) 3241-3250.
71. S.-K. Kong, M.B. Yim, E.R. Stadtman, P.B. Chock, Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide, Proc. Natl. Acad. Sci. USA 93 (1996) 3377-3382.
72. V. Kostic, V. Jackson-Lewis, F. de Bilbao, M. Dubois-Dauphin, S. Przedborski, BCL-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis, Science 277 (1997) 559-562.
73. C. Krieger, K. Jones, S.U. Kim, A.A. Eisen, The role of intracellular free calcium in motor neuron disease, J. Neurol. Sci. 124 (1994) 27-32, (Suppl.).
74. M.H. Krinks, C.B. Klee, H.C. Pant, H. Gainer, Identification and quantification of calcium-binding proteins in squid axoplasm, J. Neurosci. 8 (1988) 2172-2182.
75. C.B. Kunst, E. Mezey, M.J. Brownstein, D. Patterson, Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions, Nature Genet. 15 (1997) 91-94.
76. M.K. Lee, D.W. Cleveland, Neuronal intermediate filaments, Annu. Rev. Neurosci. 19 (1996) 187-217.
77. M.K. Lee, J.R. Marszalek, D.W. Cleveland, A mutant neurofilament subunit causes massive, selective motor neuron death: implication for the pathogenesis of human motor neuron disease, Neuron 13 (1994) 975-988.
78. M.K. Lee, Z. Xu, P.C. Wong, D.W. Cleveland, Neurofilaments are obligate heteropolymers in vivo, J. Cell Biol. 122 (1993) 1337-1350.
79. S. Lefebvre, W.E. Mushynski, Calcium binding to untreated and dephosphorylated porcine neurofilaments, Biochem. Biophys. Res. Commun. 145 (1987) 1006-1011.
80. S. Lefebvre, W.E. Mushynski, Characterization of the cation-binding properties of porcine neurofilaments, Biochemistry 27 (1988) 8503-8508.
81. P.N. Leigh, M. Swash, Cytoskeletal pathology in motor neuron disease, in: L.P. Rowland (Ed.), Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases, Vol. 56, Raven Press, New York, 1991, pp. 115-124.
82. C.-L.G. Lin, L.A. Bristol, L. Jin, M. Dykes-Hoberg, T. Crawford, L. Clawson, J.D. Rothstein, Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis, Neuron 20 (1998) 589-602.
83. P.-M. Lledo, B. Somasundaram, A.J. Morton, P.C. Emson, W.T. Mason, Stable transfection of calbindin-D28k into the GH3 cell line alters calcium currents and intracellular calcium homeostasis, Neuron 9 (1992) 943-954.
84. V. Manetto, N.H. Sternberger, G. Perry, L.A. Sternberger, P. Gambetti, Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis, J. Neuropathol. Exp. Neurol. 47 (1988) 642-653.
85. J.E. Margulies, R.W. Cohen, M.S. Levine, J.B. Watson, Decreased GluR2(B) receptor subunit mRNA expression in cerebellar neurons at risk for degeneration, Dev. Neurosci. 15 (1993) 110-120.
86. M.P. Mattson, B. Rychlik, C. Chu, S. Christakos, Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons, Neuron 6 (1991) 41-51.
87. E.W. McCleskey, Calcium channels: cellular roles and molecular mechanisms, Curr. Opin. Neurobiol. 4 (1994) 304-312.
88. B. Meldrum, J. Garthwaite, Excitatory amino acid neurotoxicity and neurodegenerative disease, Trends Pharmacol. Sci. 11 (1990) 379-387.
89. H. Mizusawa, S. Matsumoto, S.-H. Yen, A. Hirano, R.R. Rojas-Corona, H. Donnenfeld, Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis, Acta Neuropathol. 79 (1989) 37-43.
90. B.M. Morrison, J.W. Gordon, M.E. Ripps, J.H. Morrison, Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: neurochemical correlates of selective vulnerability, J. Comp. Neurol. 373 (1996) 619-631.
91. B.M. Morrison, W.G. Janssen, J.W. Gordon, J.H. Morrison, Time course of neuropathology in the spinal cord of G86R superoxide dismutase transgenic mice, J. Comp. Neurol. 391 (1998) 64-77.
92. B.M. Morrison, W.G.M. Janssen, J.W. Gordon, J.H. Morrison, Light and electron microscopic distribution of the AMPA receptor subunit, GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice, J. Comp. Neurol. 395 (1998) 523-534.
93. Z. Mourelatos, N.K. Gonatas, A. Stieber, M.E. Gurney, M.C. Dal Canto, The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease, Proc. Natl. Acad. Sci. USA 93 (1996) 5472-5477.
94. X. Mu, R.D. Azbill, J.E. Springer, Riluzole treatment following spinal cord injury improves mitochondrial function and increases glutamate and glucose uptake, Soc. Neurosci. Abstr. 23 (1997) 541.516.
95. D.G. Munoz, C. Greene, D.P. Perl, D.J. Selkoe, Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients, J. Neuropathol. Exp. Neurol. 47 (1988) 9-18.
96. C.R. Nishida, E.B. Gralla, J.S. Valentine, Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis, Proc. Natl. Acad. Sci. USA 91 (1994) 9906-9910.
97. C.W. Olanow, G.W. Arendash, Metals and free radicals in neurodegeneration, Curr. Opin. Neurol. 7 (1994) 548-558.
98. C.A. Pardo, Z. Xu, D.R. Borchelt, D.L. Price, S.S. Sisodia, D.W. Cleveland, Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons, Proc. Natl. Acad. Sci. USA 92 (1995) 954-958.
99. D.E. Pellegrini-Giampietro, R.S. Zukin, M.V.L. Bennett, S. Cho, W.A. Pulsinelli, Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats, Proc. Natl. Acad. Sci. USA 89 (1992) 10499-10503.
100. T.L. Perry, S. Hansen, K. Jones, Brain glutamate deficiency in amyotrophic lateral sclerosis, Neurology 37 (1987) 1845-1848.
101. A. Plaitakis, J.T. Caroscio, Abnormal glutamate metabolism in amyotrophic lateral sclerosis, Ann. Neurol. 22 (1987) 575-579.
102. A. Plaitakis, E. Constantakakis, J. Smith, The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis, Ann. Neurol. 24 (1988) 446-449.
103. R.B. Puchalski, J.-C. Louis, N. Brose, S.F. Traynelis, J. Egebjerg, V. Kukekov, R.J. Wenthold, S.W. Rogers, F. Lin, T. Moran, J.H. Morrison, S.F. Heinemann, Selective RNA editing and subunit assembly of native glutamate receptors, Neuron 13 (1994) 131-147.
104. T.D. Raabe, T. Nguyen, G.D. Bittner, Calcium-activated proteolysis of neurofilament proteins in goldfish Mauthner axons, J. Neurobiol. 26 (1995) 253-261.
105. S. Rabizadeh, E.B. Gralla, D.R. Borchelt, R. Gwinn, J.S. Valentine, S. Sisodia, P. Wong, M. Lee, H. Hahn, D.E. Bredesen, Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells, Proc. Natl. Acad. Sci. USA 92 (1995) 3024-3028.
106. A.G. Reaume, J.L. Elliott, E.K. Hoffman, N.W. Kowall, R.J. Ferrante, D.F. Siwek, H.M. Wilcox, D.G. Flood, M.F. Beal, R.H. Brown, R.W. Scott, W.D. Snider, Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury, Nature Genet. 13 (1996) 43-47.
107. K. Ren, M.A. Ruda, A comparative study of the calcium-binding proteins calbindin-D28k, calretinin, calmodulin and parvalbumin in the rat spinal cord, Brain Res. Rev. 19 (1994) 163-179.
108. M.E. Ripps, G.W. Huntley, P.R. Hof, J.H. Morrison, J.W. Gordon, Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis, Proc. Natl. Acad. Sci. USA 92 (1995) 689-693.
109. D.R. Rosen, T. Siddique, D. Patterson, D.A. Figlewicz, P. Sapp, A. Hentati, D. Donaldson, J. Goto, J.P. O'Regan, H.-X. Deng, Z. Rahmani, A. Krizus, D. McKenna-Yasek, A. Cayabyab, S.M. Gaston, R. Berger, R.E. Tanzi, J.J. Halperin, B. Herzfeldt, R. Van den Bergh, W.-Y. Hung, T. Bird, G. Deng, D.W. Mulder, C. Smyth, N.G. Laing, E. Soriano, M.A. Pericak-Vance, J. Haines, G.A. Rouleau, J.S. Gusella, H.R. Horvitz, R.H. Brown Jr., Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis, Nature 362 (1993) 59-62.
110. J.D. Rothstein, M. Dykes-Hoberg, C.A. Pardo, L.A. Bristol, L. Jin, R.W. Kuncl, Y. Kanai, M.A. Hediger, Y. Wang, J.P. Schielke, D.F. Welty, Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate, Neuron 16 (1996) 675-686.
111. J.D. Rothstein, L. Jin, M. Dykes-Hoberg, R.W. Kuncl, Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity, Proc. Natl. Acad. Sci. USA 90 (1993) 6591-6595.
112. J.D. Rothstein, R.W. Kuncl, Neuroprotective strategies in a model of chronic glutamate-mediated motor neurons toxicity, J. Neurochem. 65 (1995) 643-651.
113. J.D. Rothstein, R.W. Kuncl, L. Clawson, D.R. Cornblath, D.B. Drachman, A. Pestronk, Cerebrospinal fluid excitatory amino acids in amyotrophic lateral sclerosis, Ann. Neurol. 26 (1989) 144.
114. J.D. Rothstein, L.J. Martin, R.W. Kuncl, Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis, N. Engl. J. Med. 326 (1992) 1464-1468.
115. J.D. Rothstein, M. Van Kammen, A.I. Levey, L.J. Martin, R.W. Kuncl, Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis, Ann. Neurol. 38 (1995) 73-84.
116. S. Rowan, D.E. Fisher, Mechanisms of apoptotic cell death, Leukemia 11 (1997) 457-465.
117. J. Roy, S. Minotti, L. Dong, D.A. Figlewicz, H.D. Durham, Blockade of non-NMDA glutamate receptors protects motor neurons from toxicity of SOD-1 mutants linked to familial ALS, Soc. Neurosci. Abstr. 23 (1997) 742-749.
118. S. Shimuzu, Y. Eguchi, W. Kamiike, S. Waguri, Y. Uchiyama, H. Matsuda, Y. Tsujimoto, Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors, Oncogene 13 (1996) 21-29.
119. T. Siddique, H.-X. Deng, Genetics of amyotrophic lateral sclerosis, Hum. Mol. Genet. 5 (1996) 1465-1470.
120. R.G. Smith, S. Hamilton, F. Hofmann, T. Schneider, W. Nastainczyk, L. Birnbaumer, E. Stefani, S.H. Appel, Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis, N. Engl. J. Med. 327 (1992) 1721-1728.
121. B. Sommer, M. Kohler, R. Sprengel, P.H. Seeburg, RNA editing in brain controls a determinant of ion flow in glutamate-gated channels, Cell 67 (1991) 11-19.
122. R.A. Swanson, J. Liu, J.W. Miller, J.D. Rothstein, K. Farrell, B.A. Stein, M.C. Longuemare, Neuronal regulation of glutamate transporter subtype expression in astrocytes, J. Neurosci. 17 (1997) 932-940.
123. R. Tandan, Clinical features and differential diagnosis of classical motor neuron disease, in: A.C. Williams (Ed.), Motor Neuron Disease, Chapman & Hall, London, 1994, pp. 3-28.
124. D. Troost, P.A.E. Sillevis Smitt, J.M.B.V. de Jong, D.F. Swaab, Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis, Acta Neuropathol. 84 (1992) 664-673.
125. D. Trotti, D. Rossi, O. Gjesda, L.M. Levy, G. Racagni, N.C. Danbolt, A. Volterra, Peroxynitrite inhibits glutamate transporter subtypes, J. Biol. Chem. 271 (1996) 5976-5979.
126. T. Tsuda, S. Munthasser, P.E. Fraser, M.E. Percy, I. Rainero, G. Vaula, L. Pinessi, L. Bergamini, G. Vignocchi, D.R. Crapper McLachlan, W.G. Tatton, P. St George-Hyslop, Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis, Neuron 13 (1994) 727-736.
127. P.-H. Tu, P. Raju, K.A. Robinson, M.E. Gurney, J.Q. Trojanowski, V.M.-Y. Lee, Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions, Proc. Natl. Acad. Sci. USA 93 (1996) 3155-3160.
128. S.A.B.E. van Acker, L.M.H. Koymans, A. Bast, Molecular pharmacology of vitamin E: structural aspects of antioxidant activity, Free Rad. Biol. Med. 15 (1993) 311-328.
129. A. van der Vliet, J.P. Eiserich, C.A. O'Neill, B. Halliwell, C.E. Cross, Tyrosine modification by reactive nitrogen species: a closer look, Arch. Biochem. Biophys. 319 (1995) 341-349.
130. 2+ loads, J. Neurophys. 72 (1994) 2563-2569.
131. S. Wang, A. Hamberger, Q. Yang, K.G. Haglid, Changes in neurofilament protein NF-L and NF-H immunoreactivity following kainic acid-induced seizures, J. Neurochem. 62 (1994) 739-748.
132. J.H. Weiss, D.W. Choi, Slow non-NMDA receptor mediated neurotoxicity and amyotrophic lateral sclerosis, in: L.P. Rowland (Ed.), Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases, Vol. 56, Raven Press, 1991, pp. 311-318.
133. J.L. Werth, S.A. Thayer, Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons, J. Neurosci. 14 (1994) 348-356.
134. 2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons, J. Neurosci. 15 (1995) 1318-1328.
135. M. Wiedau-Pazos, J.J. Goto, S. Rabizadeh, E.B. Gralla, J.A. Roe, M.K. Lee, J.S. Valentine, D.E. Bredesen, Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis, Science 271 (1996) 515-518.
136. T.L. Williamson, L.I. Bruijn, K. Anderson, J.-P. Julien, D.W. Cleveland, Are neurofilaments necessary for the pathogenesis of SOD1 mediated ALS in mice? Soc. Neurosci. Abstr. 23 (1997) 870.873.
137. P.C. Wong, C.A. Pardo, D.R. Borchelt, M.K. Lee, N.G. Copeland, N.A. Jenkins, S.S. Sisodia, D.W. Cleveland, D.L. Price, An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria, Neuron 14 (1995) 1105-1116.
138. Z. Xu, L.C. Cork, J.W. Griffin, D.W. Cleveland, Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease, Cell 73 (1993) 23-33.
139. m for hydrogen peroxide, Proc. Natl. Acad. Sci. USA 93 (1996) 5709-5714.
140. B. Zhang, P.-H. Tu, F. Abtahian, J.Q. Trojanowski, V.M.-Y. Lee, Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation, J. Cell Biol. 139 (1997) 1307-1315.